Fundraising Fox

Wugen

St. Louis, US · Founded 2018 · Delaware corporation · 6 known investors

wugen.com ↗

Allotera (formerly Wugen) develops allogeneic T-cell therapies. The company focuses on cell and gene therapy approaches for treating disease.

BiotechHealthtechMedical Devices

Founders & leadership

AK
Ayman KabakibiExecutive Officer
DD
Drew DennisonDirector
NO
Niall O'DonnellDirector
BH
Bosun HauDirector
KL
Kevin LiDirector
PK
Peter KienerDirector
MC
Matthew CooperExecutive Officer
CT
Cherry ThomasExecutive Officer
KS
Kumar SrinivasanExecutive Officer, Director
KV
Keith VendolaExecutive Officer
DM
Daniel M KempExecutive Officer, Director
JP
John P McKearnDirector

Investors · 6

Aisling CapitalNew York
Alpha Wave GlobalMiami
BioGenerator VenturesSt. Louis · $50K – $250K
RiverVest Venture PartnersSt. Louis · $500K – $3M
Abingworthreported · 2 sourcesLondon · $15M – $30Mvia Bali Muralidhar · board
RiverVest VenturereportedSt. Louisvia Niall O’Donnell · board

Reported raises · per SEC filings

Form D private placements
▶$123.3MraisedJul 2026 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Niall O'DonnellDirector
  • Bali MuralidharDirector
  • Peter KienerDirector
  • Drew DennisonDirector
  • Kevin LiDirector
  • Bosun HauDirector
  • Matthew CooperExecutive Officer
  • Ayman KabakibiExecutive Officer
  • Natalie MountDirector
  • Kumar SrinivasanExecutive Officer, Director
  • Cherry ThomasExecutive Officer
Offering amount
$163M
Amount sold
$123.3M
First sale
Aug 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$98.5MraisedJul 2021 · 27 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel M KempExecutive Officer, Director
  • Bali MuralidharDirector
  • Ayman KabakibiExecutive Officer
  • John P McKearnDirector
  • Bosun HauDirector
  • Peter KienerDirector
  • Jan K DavidsonExecutive Officer
  • Matthew CooperExecutive Officer
  • Kevin LiDirector
  • Drew DennisonDirector
Offering amount
$172M
Amount sold
$98.5M
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37.2MraisedJul 2021 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ayman KabakibiExecutive Officer
  • Jan K DavidsonExecutive Officer
  • Kevin LiDirector
  • John P. McKearnDirector
  • Matthew CooperExecutive Officer
  • Bali MuralidharDirector
  • Peter KienerDirector
  • Drew DennisonDirector
  • Bosun HauDirector
  • Daniel M KempExecutive Officer, Director
Offering amount
$37.2M
Amount sold
$37.2M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news